
Citinerz-P 500mg/800mg Tablet
Marketer
Zanetaz Medicorp
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citinerz-P 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets are prescribed for stroke recovery and cognitive enhancement. This medication safeguards brain cells from injury and facilitates their repair, also finding application in brain injury treatment. NeuroMend 500mg/800mg tablets can be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's dosage and duration instructions precisely. If a dose is missed, take it immediately upon recollection. Complete the prescribed course, even with symptom improvement. Abrupt cessation should be avoided without consulting your doctor, as it may exacerbate symptoms. Potential side effects include increased activity levels, abdominal discomfort, anxiety, and hypotension, though these are generally transient. Consult your doctor if side effects persist or are troublesome. Maintain adequate hydration due to potential diarrhea. Weight gain is possible; counteract this through balanced nutrition and regular physical activity.
Uses of Citinerz-P 500mg/800mg Tablet
Stroke Recovery Program
Major Benefits of Citinerz-P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Citinerz-P 500mg/800mg Tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. These tablets can be taken with or without food, but maintaining a consistent administration time is recommended.
Common Side effects of Citinerz-P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citinerz-P 500mg/800mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citinerz-P 500mg/800mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Citinerz-P 500mg/800mg Tablet works:
Combining citicoline (500mg) and piracetam (800mg), Citinerz-P tablets offer neuroprotective benefits. Citicoline acts as a neuronal nutrient, shielding nerve cells from harm and enhancing their viability. Piracetam, a GABA analog, safeguards the brain and nervous system from oxygen deprivation and modulates ion channel activity within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Citinerz-P 500mg/800mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citinerz-P 500mg/800mg tablets in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Citinerz-P 500mg/800mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Citinerz-P 500mg/800mg Tablets, which can induce drowsiness and tremors. Side effects from Citinerz-P 500mg/800mg Tablets may impact driving capabilities.
KidneyCAUTION
Patients with kidney impairment should use Citinerz-P 500mg/800mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Citinerz-P 500mg/800mg tablets are contraindicated in individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Citinerz-P 500mg/800mg tablets in patients with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is advised.
What if you forget to take Citinerz-P 500mg/800mg Tablet :
Should you forget to take a Citinerz-P 500mg/800mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Citinerz-P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
